Boult Wade Tennant patent opposition analysis

The comprehensive analysis of Boult Wade Tennant opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Boult Wade Tennant

Patent NumberTitleApplicantOpposition DateOpposition Company
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression Innpm1MEMORIAL SLOAN KETTERING CANCER CENTERApr 8, 2026BOULT WADE TENNANT
Vacuum Cleaner AssemblyAKTIEBOLAGET ELECTROLUXApr 1, 2026DYSON TECHNOLOGY
Food Compositions For Weight ManagementNESTLEMar 10, 2026ABBOTT
Insulin Control In Overweight Or Obese Adult During Life Time InterventionNUTRICIAJan 19, 2026ABBOTT
Toxicity Management For Anti-Tumor Activity Of CarsTHE CHILDRENS HOSPITAL OF PHILADELPHIAJan 13, 2026BOULT WADE TENNANT
Chimeric Antigen Receptors Targeting B-Cell Maturation AntigenTHE USA REPRESENTED BY THE SECRETARYDec 31, 2025BOULT WADE TENNANT
Powders Containing A Buffer Salt And An Amino Acid, Reconstitution Of Such A Powder Into A Nutritional Product, And Methods Of Using Such A Nutritional ProductNESTLENov 14, 2025ABBOTT
Infant Formula For Feeding Infants Receiving Infant Formula And Human Breast MilkNUTRICIANov 11, 2025ABBOTT
Method And Compositions For Cellular ImmunotherapyFRED HUTCHINSON CANCER RESEARCH CENTEROct 8, 2025BOULT WADE TENNANT
Polyethylene Pipe Resin With High Resistance To Slow Crack GrowthBOREALISSep 24, 2025THE DOW CHEMICAL